Circadian system disorder induced by aberrantly activated EFNB2-EPHB2 axis leads to facilitated liver metastasis in gastric cancer
- PMID: 39298082
- DOI: 10.1007/s13402-024-00991-1
Circadian system disorder induced by aberrantly activated EFNB2-EPHB2 axis leads to facilitated liver metastasis in gastric cancer
Abstract
Background: Liver is one of the most preferred destinations for distant metastasis of gastric cancer (GC) and liver metastasis usually predicts poor prognosis. The achievement of liver metastasis requires continued cross-talk of complex members in tumor microenvironment (TME) including tumor associated macrophages (TAMs).
Methods: Results from 35 cases of ex vivo cultured living tissues of GC liver metastasis have elucidated that circadian rhythm disorder (CRD) of key molecules involved in circadian timing system (CTS) facilitates niche outgrowth. We next analyzed 69 cases of liver metastasis from patients bearing GC and designed co-culture or 3D cell culture, discovering that TAMs expressing EFNB2 could interact with tumor cell expressing EPHB2 for forward downstream signaling and lead to CRD of tumor cells. Moreover, we performed intrasplenic injection models assessed by CT combined 3D organ reconstruction bioluminescence imaging to study liver metastasis and utilized the clodronate treatment, bone marrow transplantation or EPH inhibitor for in vivo study followed by exploring the clinical therapeutic value of which in patient derived xenograft (PDX) mouse model.
Results: Ex vivo studies demonstrated that CRD of key CTS molecules facilitates niche outgrowth in liver metastases. In vitro studies revealed that TAMs expressing EFNB2 interact with tumor cells expressing EPHB2, leading to CRD and downstream signaling activation. The underlying mechanism is the enhancement of the Warburg effect in metastatic niches.
Conclusion: Overall, we aim to uncover the mechanism in TAMs induced CRD which promotes liver metastasis of GC and provide novel ideas for therapeutic strategies.
Keywords: EFNB2-EPHB2 axis; Gastric cancer; Liver metastasis; Tumor microenvironment; Warburg effect.
© 2024. Springer Nature Switzerland AG.
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
Similar articles
-
Lysyl oxidase promotes liver metastasis of gastric cancer via facilitating the reciprocal interactions between tumor cells and cancer associated fibroblasts.EBioMedicine. 2019 Nov;49:157-171. doi: 10.1016/j.ebiom.2019.10.037. Epub 2019 Oct 31. EBioMedicine. 2019. PMID: 31678002 Free PMC article.
-
Interaction between the EPHB2 receptor and EFNB1 ligand drives gastric cancer invasion and metastasis via the Wnt/β-catenin/FAK pathway.Int J Biol Macromol. 2024 Feb;258(Pt 1):128848. doi: 10.1016/j.ijbiomac.2023.128848. Epub 2023 Dec 17. Int J Biol Macromol. 2024. PMID: 38114003
-
EphB and Ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells.Stem Cells Dev. 2013 Oct 15;22(20):2751-64. doi: 10.1089/scd.2012.0676. Epub 2013 Jun 29. Stem Cells Dev. 2013. PMID: 23711177 Free PMC article.
-
The Value of EphB2 Receptor and Cognate Ephrin Ligands in Prognostic and Predictive Assessments of Human Breast Cancer.Int J Mol Sci. 2021 Jul 28;22(15):8098. doi: 10.3390/ijms22158098. Int J Mol Sci. 2021. PMID: 34360867 Free PMC article.
-
Regulation of regulatory T cells and tumor-associated macrophages in gastric cancer tumor microenvironment.Cancer Med. 2024 Jan;13(2):e6959. doi: 10.1002/cam4.6959. Cancer Med. 2024. PMID: 38349050 Free PMC article. Review.
Cited by
-
FBXO32 promotes gastric cancer progression by regulating NME1.Transl Cancer Res. 2025 Jun 30;14(6):3520-3531. doi: 10.21037/tcr-2024-2426. Epub 2025 Jun 27. Transl Cancer Res. 2025. PMID: 40687258 Free PMC article.
-
The role of macrophages in liver metastasis: mechanisms and therapeutic prospects.Front Immunol. 2025 Feb 17;16:1542197. doi: 10.3389/fimmu.2025.1542197. eCollection 2025. Front Immunol. 2025. PMID: 40034694 Free PMC article. Review.
References
-
- H. Sung, J. Ferlay, R.L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, F. Bray, Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71(3), 209–249 (2021). https://doi.org/10.3322/caac.21660 - DOI - PubMed
-
- L.P. Carcas, Gastric cancer review. J. Carcinog. 13, 14 (2014). https://doi.org/10.4103/1477-3163.146506 - DOI - PubMed - PMC
-
- P. Yang, Q.J. Li, Y. Feng, Y. Zhang, G.J. Markowitz, S. Ning, Y. Deng, J. Zhao, S. Jiang, Y. Yuan et al., TGF-beta-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. Cancer Cell. 22(3), 291–303 (2012). https://doi.org/10.1016/j.ccr.2012.07.023 - DOI - PubMed - PMC
-
- K. Shitara, J. Ikeda, C. Kondo, D. Takahari, T. Ura, K. Muro, K. Matsuo, Reporting patient characteristics and stratification factors in randomized trials of systemic chemotherapy for advanced gastric cancer. Gastric Cancer. 15(2), 137–143 (2012). https://doi.org/10.1007/s10120-011-0083-8 - DOI - PubMed
-
- C. Dibner, U. Schibler, U. Albrecht, The mammalian circadian timing system: organization and coordination of central and peripheral clocks. Annu. Rev. Physiol. 72, 517–549 (2010). https://doi.org/10.1146/annurev-physiol-021909-135821 - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous